Position in NVS
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$370,329
+$9,381 QoQ
Shares Held
2,363
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,024
of 1,603 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAPIENT CAPITAL LLC holds $1,835,997,515 across 11 Drug Manufacturers - General names. NVS ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,447,540 | $1,736,223,046 | |
| 2 | ABBV |
AbbVie Inc.
|
196,236 | $49,380,827 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
165,115 | $20,860,629 | |
| 4 | JNJ |
Johnson & Johnson
|
49,415 | $12,549,927 | |
| 5 | PFE |
Pfizer Inc
|
427,068 | $10,283,797 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
37,372 | $2,153,374 | |
| 7 | AZN |
Astrazeneca PLC
|
8,592 | $1,629,215 | |
| 8 | AMGN |
Amgen Inc
|
2,757 | $998,364 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,329 | 2,363 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $360,948 | 2,363 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $261,677 | 1,898 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $222,368 | 1,734 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $209,831 | 1,734 | Shares | Sole | 2025-07-09 | |
| 2024-03-31 | $223,252 | 2,308 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $271,407 | 2,688 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||